New COVID-19 Antibody Study

Netanya Utay, MD, and a clinical trial participant spoke to KTRK-TV Channel 13 about the ACTIV-2 trial led by a team of infectious disease experts at UTHealth. The team is studying various therapies, including monoclonal antibodies, for non-hospitalized patients with mild COVID-19.

October 15, 2020